Medical - Healthcare Plans
Compare Stocks
2 / 10Stock Comparison
UNH vs MCK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Distribution
UNH vs MCK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Distribution |
| Market Cap | $330.28B | $98.11B |
| Revenue (TTM) | $449.71B | $397.96B |
| Net Income (TTM) | $12.04B | $4.34B |
| Gross Margin | 18.8% | 3.4% |
| Operating Margin | 4.2% | 1.3% |
| Forward P/E | 19.9x | 20.5x |
| Total Debt | $78.39B | $7.39B |
| Cash & Equiv. | $24.36B | $5.69B |
UNH vs MCK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| UnitedHealth Group … (UNH) | 100 | 119.4 | +19.4% |
| McKesson Corporation (MCK) | 100 | 504.8 | +404.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UNH vs MCK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UNH is the clearest fit if your priority is income & stability.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- Lower P/E (19.9x vs 20.5x)
- 2.7% margin vs MCK's 1.1%
MCK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
- 375.1% 10Y total return vs UNH's 217.0%
- Lower volatility, beta 0.04, current ratio 0.90x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.2% revenue growth vs UNH's 11.8% | |
| Value | Lower P/E (19.9x vs 20.5x) | |
| Quality / Margins | 2.7% margin vs MCK's 1.1% | |
| Stability / Safety | Beta 0.04 vs UNH's 0.59 | |
| Dividends | 2.4% yield, 25-year raise streak, vs MCK's 0.3% | |
| Momentum (1Y) | +13.7% vs UNH's -7.9% | |
| Efficiency (ROA) | 5.3% ROA vs UNH's 3.9%, ROIC 5.4% vs 9.2% |
UNH vs MCK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
UNH vs MCK — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
UNH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH and MCK operate at a comparable scale, with $449.7B and $398.0B in trailing revenue. Profitability is closely matched — net margins range from 2.7% (UNH) to 1.1% (MCK). On growth, MCK holds the edge at +11.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $449.7B | $398.0B |
| EBITDAEarnings before interest/tax | $23.2B | $5.8B |
| Net IncomeAfter-tax profit | $12.0B | $4.3B |
| Free Cash FlowCash after capex | $19.7B | $10.1B |
| Gross MarginGross profit ÷ Revenue | +18.8% | +3.4% |
| Operating MarginEBIT ÷ Revenue | +4.2% | +1.3% |
| Net MarginNet income ÷ Revenue | +2.7% | +1.1% |
| FCF MarginFCF ÷ Revenue | +4.4% | +2.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +11.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +0.7% | +38.2% |
Valuation Metrics
UNH leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 27.5x trailing earnings, UNH trades at a 12% valuation discount to MCK's 31.1x P/E. On an enterprise value basis, UNH's 16.5x EV/EBITDA is more attractive than MCK's 19.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $330.3B | $98.1B |
| Enterprise ValueMkt cap + debt − cash | $384.3B | $99.8B |
| Trailing P/EPrice ÷ TTM EPS | 27.50x | 31.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.87x | 20.53x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.80x |
| EV / EBITDAEnterprise value multiple | 16.48x | 19.93x |
| Price / SalesMarket cap ÷ Revenue | 0.74x | 0.27x |
| Price / BookPrice ÷ Book value/share | 3.26x | — |
| Price / FCFMarket cap ÷ FCF | 20.55x | 18.77x |
Profitability & Efficiency
MCK leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +11.5% | — |
| ROA (TTM)Return on assets | +3.9% | +5.3% |
| ROICReturn on invested capital | +9.2% | +5.4% |
| ROCEReturn on capital employed | +9.7% | +30.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.77x | — |
| Net DebtTotal debt minus cash | $54.0B | $1.7B |
| Cash & Equiv.Liquid assets | $24.4B | $5.7B |
| Total DebtShort + long-term debt | $78.4B | $7.4B |
| Interest CoverageEBIT ÷ Interest expense | 4.71x | 25.04x |
Total Returns (Dividends Reinvested)
MCK leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCK five years ago would be worth $43,011 today (with dividends reinvested), compared to $9,722 for UNH. Over the past 12 months, MCK leads with a +13.7% total return vs UNH's -7.9%. The 3-year compound annual growth rate (CAGR) favors MCK at 30.3% vs UNH's -7.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +8.8% | -2.6% |
| 1-Year ReturnPast 12 months | -7.9% | +13.7% |
| 3-Year ReturnCumulative with dividends | -21.4% | +121.2% |
| 5-Year ReturnCumulative with dividends | -2.8% | +330.1% |
| 10-Year ReturnCumulative with dividends | +217.0% | +375.1% |
| CAGR (3Y)Annualised 3-year return | -7.7% | +30.3% |
Risk & Volatility
Evenly matched — UNH and MCK each lead in 1 of 2 comparable metrics.
Risk & Volatility
MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 88.8% from its 52-week high vs MCK's 80.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.59x | 0.04x |
| 52-Week HighHighest price in past year | $409.70 | $999.00 |
| 52-Week LowLowest price in past year | $234.60 | $637.00 |
| % of 52W HighCurrent price vs 52-week peak | +88.8% | +80.2% |
| RSI (14)Momentum oscillator 0–100 | 83.3 | 27.7 |
| Avg Volume (50D)Average daily shares traded | 8.1M | 690K |
Analyst Outlook
UNH leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates UNH as "Buy" and MCK as "Buy". Consensus price targets imply 25.7% upside for MCK (target: $1007) vs 5.9% for UNH (target: $385). For income investors, UNH offers the higher dividend yield at 2.39% vs MCK's 0.34%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $385.43 | $1006.50 |
| # AnalystsCovering analysts | 52 | 31 |
| Dividend YieldAnnual dividend ÷ price | +2.4% | +0.3% |
| Dividend StreakConsecutive years of raises | 25 | 17 |
| Dividend / ShareAnnual DPS | $8.70 | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.7% | +3.2% |
UNH leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MCK leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.
UNH vs MCK: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is UNH or MCK a better buy right now?
For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.
2% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 5x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UNH or MCK?
On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 27.
5x versus McKesson Corporation at 31. 1x. On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 19. 9x.
03Which is the better long-term investment — UNH or MCK?
Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +330.
1%, compared to -2. 8% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: MCK returned +375. 1% versus UNH's +217. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UNH or MCK?
By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.
04β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 1261% more volatile than MCK relative to the S&P 500.
05Which is growing faster — UNH or MCK?
By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.
2% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: McKesson Corporation grew EPS 14. 9% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UNH or MCK?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus 0. 9% for McKesson Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 1. 2% for MCK. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UNH or MCK more undervalued right now?
On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 19.
9x forward P/E versus 20. 5x for McKesson Corporation — 0. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MCK: 25. 7% to $1006. 50.
08Which pays a better dividend — UNH or MCK?
All stocks in this comparison pay dividends.
UnitedHealth Group Incorporated (UNH) offers the highest yield at 2. 4%, versus 0. 3% for McKesson Corporation (MCK).
09Is UNH or MCK better for a retirement portfolio?
For long-horizon retirement investors, McKesson Corporation (MCK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
04), +375. 1% 10Y return). Both have compounded well over 10 years (MCK: +375. 1%, UNH: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UNH and MCK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: UNH is a large-cap quality compounder stock; MCK is a mid-cap high-growth stock. UNH pays a dividend while MCK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.